FAP and neoplasm: Pharmacological blockade of CXCR4 or abrogation of its main source CAFs by introducing a diphtheria toxin receptor-expressing Fap transgene leading to eradication of Fap expressing CAFs upon diphtheria toxin administration in a mouse model of PDAC altered the composition of the TME and increased T-cell invasion into the tumour.